ProPhase Labs, Inc. Assets Held-for-sale, Not Part of Disposal Group, Current
ProPhase Labs, Inc. (PRPH) had Assets Held-for-sale, Not Part of Disposal Group, Current of $176.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-19.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent · last filed 2020-11-19
- 2020-09-30: Assets Held-for-sale, Not Part of Disposal Group, Current $176.00K.
- 2020-06-30: Assets Held-for-sale, Not Part of Disposal Group, Current $176.00K.
- 2017-12-31: Assets Held-for-sale, Not Part of Disposal Group, Current $22.00K.
- 2017-09-30: Assets Held-for-sale, Not Part of Disposal Group, Current $22.00K.
| Period end | Assets Held-for-sale, Not Part of Disposal Group, Current |
|---|---|
| 2020-09-30 | $176.00K 10-Q · filed 2020-11-19 |
| 2020-06-30 | $176.00K 10-Q · filed 2020-08-11 |
| 2017-12-31 | $22.00K 10-K · filed 2019-03-26 |
| 2017-09-30 | $22.00K 10-Q · filed 2018-11-14 |
| 2017-06-30 | $294.00K 10-Q/A · filed 2018-08-20 |
| 2017-03-31 | $699.00K 10-Q/A · filed 2018-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |